POSSIBLE EFFECT OF ATORVASTATIN IN PREVENTING HEMORRHAGIC CYSTITIS INDUCED BY CYCLOPHOSPHAMIDE IN RATS

Cyclophosphamide (CP) is an antineoplastic agent used for the treatment of many neoplastic and inflammatory diseases. Hemorrhagic cystitis is a frequent side effect of CP. Several studies show’s that atorvastatin has importantpleiotropic (anti-inflammatory and immunomodulatory) effects. The purpose of the study was to investigate the effect of atorvastatin in prevention from HC induced by CP. Thirty rats were divided into 5 main groups: Control, CP,CP and MESNA, CP and Atorvastatin, CP- MESNA and Atorvastatin. The bladder was collected and histopathological evaluated. Atorvastatin Show’s significant reduction in HC scoring, MESNA still superior than Atorvastatin inprevention of HC, combination both Ator And MESNA show’s no additive effect.

Authors

Institutions

Publication Details

Journal
Misurata Medical Sciences Journal
Published
2025-06-15
DOI
https://doi.org/10.36602/mmsj/2016.n04.11
Primary Topic
Ovarian cancer diagnosis and treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

POSSIBLE EFFECT OF ATORVASTATIN IN PREVENTING HEMORRHAGIC CYSTITIS INDUCED BY CYCLOPHOSPHAMIDE IN RATS

Jamal Dammona, Khaled Makhluf Elzergani, Najlla Alborke, Nada Alreahy
Misurata Medical Sciences Journal
Ovarian cancer diagnosis and treatment
article

POSSIBLE EFFECT OF ATORVASTATIN IN PREVENTING HEMORRHAGIC CYSTITIS INDUCED BY CYCLOPHOSPHAMIDE IN RATS

Jamal Dammona, Khaled Makhluf Elzergani, Najlla Alborke, Nada Alreahy
article en

Abstract

Cyclophosphamide (CP) is an antineoplastic agent used for the treatment of many neoplastic and inflammatory diseases. Hemorrhagic cystitis is a frequent side effect of CP. Several studies show’s that atorvastatin has importantpleiotropic (anti-inflammatory and immunomodulatory) effects. The purpose of the study was to investigate the effect of atorvastatin in prevention from HC induced by CP. Thirty rats were divided into 5 main groups: Control, CP,CP and MESNA, CP and Atorvastatin, CP- MESNA and Atorvastatin. The bladder was collected and histopathological evaluated. Atorvastatin Show’s significant reduction in HC scoring, MESNA still superior than Atorvastatin inprevention of HC, combination both Ator And MESNA show’s no additive effect.

Misurata Medical Sciences JournalVol. 3(1)
Misurata University (LY)
Openalex Percentile: Top 63%
Ovarian cancer diagnosis and treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.